Ahmet Tezel, PhD, was named Johnson & Johnson MedTech's company group chair and global head of medtech innovation and R&D.
Dr. Tezel replaces Peter Shen, PhD, who retired, according to a Nov. 7 company news release shared with Becker's. In his role, he will be responsible for end-to-end elements of reserach and development for the company.
He previously worked as vice president of R&D at Ethicon.
Johnson & Johnson MedTech includes orthopedic technology. The company named Kurt Van den Bosch as CFO in May.